Where does NeoTract, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeoTract, Inc. ranks #9,569 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeoTract, Inc. hold?

NeoTract, Inc. holds 33 US utility patents granted between 2015 and 2021, spanning 3 technology areas.

What is NeoTract, Inc.'s Innovation Score?

NeoTract, Inc. has an Innovation Score of 26.9 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeoTract, Inc. focus on?

NeoTract, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 33 patents, ranking #577 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is NeoTract, Inc.'s patent grant rate increasing or decreasing?

NeoTract, Inc.'s recent grant velocity is -73% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NeoTract, Inc.'s patents?

NeoTract, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeoTract, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeoTract, Inc.

USPTO PatentsView assignee record - 33 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neotract ranks #9,569 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 3 technology areas.

#9,569
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (26.9/100): 14.3
avg claims per patent: -73%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9569 · US Corporation #9,569 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,569/49,997
PHOTO-FINISH Nanjing Easthouse…
CPC-NARROW A61B · 3 areas
INNOV-THIN 26.9/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -73% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanjing Easthouse Electrical Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neotract’s 26.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (45%) Velocity 0.0 pts (0%) Breadth 6.1 pts (23%) Claim depth 8.6 pts (32%)

Qualcomm Incorporated · highest

85
Hinkley Lighting · near

27
NeoTract · this assignee

27
TWC Patent Trust LLT · near

27
Scholl's Wellness · near

27
Thule · near

27
3D Lighting… · lowest

7

What this shows Neotract's Innovation Score is 26.9/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neotract?

Each dot is one of Neotract’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neotract’s own 14.3 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Neotract vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neotract's grants concentrate

NeoTract, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (8 grants) versus a trough of 1 in 2017. By volume, Neotract sits between Nidec-shimpo Corporation and Oculeve, Inc..

Nidec-shimpo

33
Nanjing Easthouse…

33
Narus

33
National Institut…

33
Nomadix

33
North Carolina Ag…

33
Novozymes North A…

33
Oculeve

33
Neotract ◀

33

What this shows NeoTract holds 33 patents at rank #9,571, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeoTract

By rank, the assignees closest to #9,571 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NeoTract's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NeoTract, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), NeoTract ranks #577 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (27 here).

TWC Patent Trust LLT 27 Thule NV 27 Hinkley Lighting, Inc. 27 Scholl's Wellness Company LLC 27

Neotract's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NeoTract, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	21.2%
2016	5	15.2%
2017	1	3.0%
2018	5	15.2%
2019	8	24.2%
2020	2	6.1%
2021	5	15.2%

Which technologies does NeoTract, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 33

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 16

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NeoTract, Inc.'s patent record in context - here's where to go next.

NeoTract, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #9,569 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeoTract, Inc. against Nidec-shimpo Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.